Estrous cycle variation in anxiolytic-like effects of topiramate in Wistar rats in two animal models of anxiety-like behavior.

Pharmacol Biochem Behav

Laboratorio de Psicobiología y Etología, Instituto de Investigaciones Psicológicas, Universidad Veracruzana, Jalapa, Veracruz, Mexico.

Published: January 2013

AI Article Synopsis

  • The study examined the anxiolytic effects of topiramate and diazepam on Wistar rats during different phases of the estrous cycle.
  • Both drugs showed increased responses in anxiety-like behaviors during the proestrus phase at lower doses, while higher doses were necessary during metestrus-diestrus for effects to be seen.
  • The findings indicate that the effectiveness of these treatments can be influenced by the estrous cycle phase, suggesting a potential link between hormonal changes and anxiety modulation.

Article Abstract

The anxiolytic-like effects of topiramate were assessed during several estrous cycle phases in Wistar rats tested in two animal models of anxiety-like behavior. In a conflict operant test, during proestrus, diazepam (1.3, 2.0mg/kg; P<0.05) or topiramate (20.0, 30.0mg/kg; P<0.05) increased the number of immediately punished responses. During metestrus-diestrus only the highest doses of diazepam (2.0mg/kg, P<0.05) or topiramate (30.0mg/kg, P<0.05) increased the number of immediately punished reinforcers. Similar results were obtained in the elevated plus-maze test: during proestrus, diazepam (1.3, 2.0mg/kg; P<0.05) or topiramate (20.0, 30.0mg/kg; P<0.05) produced anxiolytic-like actions. During metestrus-diestrus only the highest doses of diazepam (2.0mg/kg, P<0.05) or topiramate (30.0mg/kg, P<0.05) produced anxiolytic-like actions. Neither diazepam nor topiramate nor estrous cycle phases significantly modified the number of closed arm entries in the elevated plus-maze test. It is concluded that the response to neuromodulatory drugs for anxiety-like behavior varied according to the estrous cycle phases.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pbb.2012.11.002DOI Listing

Publication Analysis

Top Keywords

estrous cycle
8
anxiolytic-like effects
8
effects topiramate
8
wistar rats
8
animal models
8
models anxiety-like
8
anxiety-like behavior
8
cycle variation
4
variation anxiolytic-like
4
topiramate wistar
4

Similar Publications

Circadian rhythm disruption (CRD), stemming from sleep disorders and/or shift work, is a risk factor for reproductive dysfunction. CRD has been reported to disturb nocturnal melatonin signaling, which plays a crucial role in female reproduction as a circadian regulator and an antioxidant. The hypothalamic-pituitary-ovarian (HPO) axis regulates female reproduction, with luteinizing hormone (LH) pulse pattern playing a pivotal role in folliculogenesis and steroidogenesis.

View Article and Find Full Text PDF

Equine endometrosis is a major cause of infertility in mares and is characterized by degenerative, functional and fibrotic changes in the endometrium with increased collagen (COL) deposition. Transforming growth factor (TGF)-β1 is one of the major pro-fibrotic factors involved in the excessive deposition of extracellular matrix (ECM) components in the equine endometrium. It has been demonstrated that ovarian steroids, specifically 17β-estradiol (E2) and progesterone (P4), not only regulate the cyclicity of the estrous cycle, but also have been implicated as anti- or pro-fibrotic factors.

View Article and Find Full Text PDF

Pancreastatin inhibitor PSTi8 improves ovarian health in Letrozole-HFD induced PCOS rats by ameliorating metabolic and reproductive parameters.

Steroids

December 2024

Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226 031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziaba 201002, India. Electronic address:

Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine and metabolic disorder associated with insulin resistance (IR) and hyperandrogenism. IR plays a crucial role in the etiology of PCOS. An insulin-sensitizing agent like metformin is most commonly used as an off-label drug for the treatment of PCOS.

View Article and Find Full Text PDF

This study aimed to evaluate the ovulatory response to GnRH treatment based on the day of its administration in the first follicular wave of the estrous cycle in goats. We hypothesized that maximum ovulatory response with GnRH treatment is dependent on the day of its administration during the early luteal phase of estrous cycle. Forty-eight goats were presynchronized with a single dose of PGF, and ultrasonography was performed to confirm ovulation (Day 0).

View Article and Find Full Text PDF

Changes in expression of FSH and LH receptors in the ovine main immune organs during early pregnancy.

Vet Immunol Immunopathol

December 2024

School of Life Sciences and Food Engineering, Hebei University of Engineering, Handan, China. Electronic address:

Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are mainly involved in follicle development and ovulation, but FSH receptor (FSHR) and LH receptor (LHR) are also expressed in the immune system. Nevertheless, it is not clear if gestation affects the expression of the FSHR and LHR in the maternal main immune organs (thymus, lymph node, spleen, and liver). In this study, these organs were sampled from the ewes at the estrous cycle, and during early pregnancy, and mRNA and protein expression of FSHR and LHR were analyzed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!